Search PubMed⌕ Search

Biomedical subjects

S Shtrasburg

Publications and source records attributed to S Shtrasburg.

20 records · Page 2Linked to original sources

Extremely active murine amyloid enhancing factor.

OBJECTIVE: To generate and characterize a highly active amyloid enhancing factor (AEF). METHODS: AEF was obtained from amyloidotic and pre-amyloidotic mice spleens that were homogenized in 50% acetone in H2O. The grade of AEF enhancing activity was studied in relation to the procedure used to generate the AEF, the amount of AEF administered, the duration of amyloid induction and the effect of solvent and denaturing agents. RESULTS: Both priming of the splenic source of the AEF with an amyloidogen and acetone processing were essential for the AEF activity. AEF in a single intravenous dose as low as 1 nanogram per mouse induced amyloidosis in mice within 2-6 days. Polyacrylamide gel electrophoresis of the AEF showed two protein bands of molecular weight (MW) 9-11 KD not present in normal spleen homogenates. Dialysis of the AEF showed that the active components can pass through a dialysis bag with an MW cutoff of 12 KD. CONCLUSIONS: These findings suggest that ours is the most active AEF currently available and that it has active constituents of low MW ( < or = 12 KD) which appear in the spleen during amyloidogenesis.

Amyloid↗

Long-term effects of amyloid enhancing factor: clinical and experimental implications.

OBJECTIVE: To study the long-term effects of amyloid enhancing factor (AEF). METHODS: AEF, prepared from pre-amyloidotic mouse spleens, was injected intravenously into Swiss and ICR mice. This was followed by 3 daily subcutaneous injections of AgNO3, given at increasing time intervals from the administration of AEF. The mice were sacrificed on day 6 from the first AgNO3 injection, and the mean grade of amyloid deposition in the spleens was estimated using the crush and smear technique. RESULTS: AEF was found to have a prolonged enhancing effect, retaining its activity for more than 3 months after its administration in both mouse strains. CONCLUSIONS: Experimental animals may develop amyloidosis long time after exposure to AEF. This finding may underlie the acute reoccurrence of amyloidosis sometimes observed in patients and mice long after its resolution.

Amyloidosis↗